Mansi Babbar

Mansi Babbar

Auto-generated profile, based on publicly available information

Mansi Babbar

Laboratory of Molecular Gerontology, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2019 in Nature Reviews Neurology
Verified
Journal Article
Closed access
PDF file
YHYujun Hou
Yujun Hou
XDXiuli Dan
Xiuli Dan
MBMansi Babbar
Mansi Babbar
YWYong Wei
Yong Wei
SHSteen Gregers Hasselbalch
Steen Gregers Hasselbalch
VBVilhelm A. Bohr
Vilhelm A. Bohr

1 March 2020 in Mechanisms of Ageing and Development
Verified
Journal Article
Closed access
MBMansi Babbar
Mansi Babbar
SBSambuddha Basu
Sambuddha Basu
BYBeimeng Yang
Beimeng Yang
DCDeborah L. Croteau
Deborah L. Croteau
VBVilhelm A. Bohr
Vilhelm A. Bohr

26 May 2020 in Nucleic Acids Research
Verified
Journal Article
Closed access
XDXiuli Dan
Xiuli Dan
MBMansi Babbar
Mansi Babbar
AMAnthony Moore
Anthony Moore
NWNoah Wechter
Noah Wechter
JTJingyan Tian
Jingyan Tian
VBVilhelm A Bohr
Vilhelm A Bohr
Mitochondria are vital for cellular energy supply and intracellular signaling after stress. Here, we aimed to investigate how mitochondria respond to acute DNA damage with respect to mitophagy, which is an important mitochondrial quality control process. Our results show that mitophagy increases after DNA damage in primary fibroblasts, murine neurons and Caenorhabditis elegans neurons. Our results indicate that modulation of mitophagy after DNA damage is independent of the type of DNA damage stimuli used and that the protein Spata18 is an important player in this process. Knockdown of Spata18 suppresses mitophagy, disturbs mitochondrial Ca2+ homeostasis, affects ATP production, and attenuates DNA repair. Importantly, mitophagy after DNA damage is a vital cellular response to maintain mitochondrial functions and DNA repair.

24 April 2020 in Acta Neuropathologica
Verified
Journal Article
Closed access
PDF file
TDTyler G. Demarest
Tyler G. Demarest
VVVijay R. Varma
Vijay R. Varma
DEDarlene Estrada
Darlene Estrada
MBMansi Babbar
Mansi Babbar
SBSambuddha Basu
Sambuddha Basu
VBVilhelm A. Bohr
Vilhelm A. Bohr

4 March 2019 in Annual Review of Cancer Biology
Verified
Journal Article
Closed access
TDTyler G. Demarest
Tyler G. Demarest
MBMansi Babbar
Mansi Babbar
MOMustafa N. Okur
Mustafa N. Okur
XDXiuli Dan
Xiuli Dan
DCDeborah L. Croteau
Deborah L. Croteau
VBVilhelm A. Bohr
Vilhelm A. Bohr
Aging is a major risk factor for many types of cancer, and the molecular mechanisms implicated in aging, progeria syndromes, and cancer pathogenesis display considerable similarities. Maintaining redox homeostasis, efficient signal transduction, and mitochondrial metabolism is essential for genome integrity and for preventing progression to cellular senescence or tumorigenesis. NAD+ is a central signaling molecule involved in these and other cellular processes implicated in age-related diseases and cancer. Growing evidence implicates NAD+ decline as a major feature of accelerated aging progeria syndromes and normal aging. Administration of NAD+ precursors such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) offer promising therapeutic strategies to improve health, progeria comorbidities, and cancer therapies. This review summarizes insights from the study of aging and progeria syndromes and discusses the implications and therapeutic potential of the underlying molecular mechanisms involved in aging and how they may contribute to tumorigenesis.